Project Partners

We thank our Project Partners 2023 for their kind support:

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.

Inspired by patients, we take health personally, because health is personal.

We innovate with purpose to lead where medicine is going.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

SIMCharacters develops paediatric simulators to improve the medical care of critically ill children. His work as a neonatologist has taught founder Jens Schwindt that a highly professional interdisciplinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergencies under highly realistic conditions.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2022 for their kind support:

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.

Inspired by patients, we take health personally, because health is personal.

We innovate with purpose to lead where medicine is going.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

SIMCharacters develops paediatric simulators to improve the medical care of critically ill children. His work as a neonatologist has taught founder Jens Schwindt that a highly professional interdisciplinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergencies under highly realistic conditions.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2021 for their kind support:

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

For 60 years now, Bübchen has been producing care products for the special needs of sensitive baby- and children skin. The complete range is produced in Germany and only uses substance combinations that guarantee excellent skin-compatibility. Today, Bübchen is a well-established venture, that millions of parents’ trust. With intensive research, optimal quality, careful selection of natural ingredients and recycled packaging Bübchen not only convince mothers worldwide, but also contribute to a healthy environment.

HOBEA-Germany is a young, family-run enterprise that is located in Germany and committed itself to the production of high-quality products for the whole family. With their focus on safety, sustainability, excellent service and a fair price, HOBEA now has been supporting parents for over 10 years in finding the perfect equipment for their children.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

SIMCharacters develops paediatric simulators to improve the medical care of critically ill children. His work as a neonatologist has taught founder Jens Schwindt that a highly professional interdisciplinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergencies under highly realistic conditions.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2020 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

SIMCharacters develops paediatric simulators to improve the medical care of critically ill children. His work as a neonatologist has taught founder Jens Schwindt that a highly professional interdisciplinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergencies under highly realistic conditions.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 237-year history in Japan.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2019 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

Lyomark Pharma GmbH was founded in Oberhaching, near Munich, in 1989 as a supplier of drug substances, drug products and R&D chemicals.
Lyomark is specialised in niche proprietary orphan drugs for rare diseases and generic products, presented as sterile injectable, lyopholisied formulations in vials and ampoules. Lyomark is active in the area of respiratory diseases, neonatology, antibiotics and antimycotics.
Marketing and sales are carried out either directly through Lyomark´s own sales force or through international partners in over 50 countries. Lyomark Pharma is the majority shareholder of Lyocontract GmbH, a state-of-the-art pharmaceutical manufacturing site in Germany. That is what Lyomark stands for: customer orientation, combined with an oustanding level of service.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

SIMCharacters develops paediatric simulators to improve the medical care of critically ill children. His work as a neonatologist has taught founder Jens Schwindt that a highly professional interdisciplinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergencies under highly realistic conditions.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 237-year history in Japan.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2018 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

Lyomark Pharma GmbH was founded in Oberhaching, near Munich, in 1989 as a supplier of drug substances, drug products and R&D chemicals.
Lyomark is specialised in niche proprietary orphan drugs for rare diseases and generic products, presented as sterile injectable, lyopholisied formulations in vials and ampoules. Lyomark is active in the area of respiratory diseases, neonatology, antibiotics and antimycotics.
Marketing and sales are carried out either directly through Lyomark´s own sales force or through international partners in over 50 countries. Lyomark Pharma is the majority shareholder of Lyocontract GmbH, a state-of-the-art pharmaceutical manufacturing site in Germany. That is what Lyomark stands for: customer orientation, combined with an oustanding level of service.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

The safe delivery of the next generation is a significant responsibility for caregivers around the world. Because every pregnancy and birth is one of a kind, and each action you take can have a lasting impact on the course of a new life. Philips is committed to working with you to provide the best care possible – from the time a woman hears the joyful news she’s about to be a mom, through pregnancy, labor and delivery, postpartum, and on to the transition home. For more than 50 years, we have shared your passion in caring for mothers, babies, and their families. As a global team of people with firsthand experience in delivering the next generation, we understand that addressing immediate concerns is just as critical as providing long-term wellbeing. Our innovative, evidence-based solutions are designed to support a baby’s development while helping newborns bond with parents and family and get off to a healthy start.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2017 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

Ferring Pharmaceuticals is a research-driven, biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and orthopaedics.

The company’s research activities and products are connected by a common focus of providing tailored treatments that work on the body’s own terms, enabling doctors to combat numerous diseases and medical conditions.

Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.

Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2016 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians.

By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

The united systems AG (Germany) was founded in 1999. united systems AG is offering reliable IT infrastructure services based on the international standards of ITIL and ISO 9001.

united systems AG focus on customers with up to 500 seats in the area of „Managed IT Service“ and outsourcing projects. In addition, united systems AG also offers expert consulting around complex Microsoft solutions, Storage solutions, Server and Client Virtualization, Software deployment and Enterprise Archive Solutions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2015 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

Reaching people, inspiring people, moving people. COMEO is made up of Advertising, PR and Event units. In all three areas, the company builds on a core of permanent specialists with in-depth professional experience, supported by outstanding rookies.

COMEO is the ideal partner for medium-sized companies and institutions from the fields of healthcare, real estate and tourism. Outstanding teamwork and high-grade drive, motivation and commitment are the hallmarks of COMEO’s work. We deliver results that reflect your wishes, comply with your budget and enhance your reputation.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Straight talking. Thinking around corners. Understanding and solving the problem before it becomes one. Delivering clear and practical advice that gets your job done.

Our 2,500 lawyers work together with you to solve the toughest legal issues in major industries and commercial centers around the world. Whether you’re expanding into new markets, considering capital from new sources, or dealing with increasingly complex regulation or disputes, we help you stay on top of your risks and opportunities.

Giving back to communities and society is fundamental to good business. And, it’s part of our core. We are advocates of justice, equality, and opportunity. Everyone at Hogan Lovells is asked to volunteer at least 25 hours a year as part of their normal work duties. Around the world, our people are making a difference through pro bono activities, community investment, and social justice.

As professional congress organisers, MCA Events helps scientific organisations and societies to plan the perfect congress or event since 1999. With their multi-faceted approach MCA consults, guides and supports their clients through the entire process. MCA is a full service event planning agency and handles every aspect in a time efficient manner, making sure all congresses and events are strategically planned, effectively organised and meet the client’s goals. The agency is used to work everywhere clients decide to hold their event: Europe, North and South America and recently in Asia. The MCA experts utilise their in-depth knowledge and strong relationships to the industry to make sure every event is a success.

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

The united systems AG (Germany) was founded in 1999. united systems AG is offering reliable IT infrastructure services based on the international standards of ITIL and ISO 9001.

united systems AG focus on customers with up to 500 seats in the area of „Managed IT Service“ and outsourcing projects. In addition, united systems AG also offers expert consulting around complex Microsoft solutions, Storage solutions, Server and Client Virtualization, Software deployment and Enterprise Archive Solutions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2014 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

Reaching people, inspiring people, moving people. COMEO is made up of Advertising, PR and Event units. In all three areas, the company builds on a core of permanent specialists with in-depth professional experience, supported by outstanding rookies.

COMEO is the ideal partner for medium-sized companies and institutions from the fields of healthcare, real estate and tourism. Outstanding teamwork and high-grade drive, motivation and commitment are the hallmarks of COMEO’s work. We deliver results that reflect your wishes, comply with your budget and enhance your reputation.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Feine Sache is a small design and advertising company in Wiesbaden near Frankfurt/Main, Germany. Feine Sache produces corporate design and corporate communication, logos, infographics, illustrations and typography for web, print, and events. Feine Sache works for brands and agencies of any size and also loves to do design for non-for-profit themes. Founded in 2003 by Michel Schmidt, Feine Sache is well-known for its typographic and illustrative skills and enjoys producing design at an international quality level.

So what is good design? Good design is more than creating the surface, and even more than structuring information in a professional way. Good design translates “the whole picture” into a unique graphic language, and in doing so, creates a vision for both, the viewer’s heart and mind.

JOKE Event Inc. is an owner-managed, full-service agency in the field of live communication. Its head office is in Bremen with additional offices in Hamburg, Düsseldorf, Berlin, Frankfurt , Stuttgart and Munich, providing services in close proximity to the clients. The team of JOKE Event Inc. distinguishes itself through imaginative concepts, convincing productions, Hanseatic quality standards, precise, hand-in-hand co-operation with all trades plus a good measure of Nordic understatement. The agency, under the direction of Christian Seidenstücker and Peter Melms, with more than 85 employees ranks among the top ten live-communication agencies nationwide according to the FME Rankings. Since 1992 JOKE Event has provided all event-related services from one source – consulting, creative concepts and realization – for companies, brands and institutions such as the AB Inbev, BMW, Bundesverband WindEnergie e.V. (BEW), Deutscher Stifterverband, Dräger Medical, EFCNI, GP Joule, Hyundai, Kia Motors, Mazda, Kellogg’s, Nissan, Vattenfall or Werder Bremen. JOKE Event founded the “Wolkenschieber”, a charity project in favor of different local charities in and around Bremen.

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Royal Philips of the Netherlands is a diversified technology company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy-efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

B·R·A·H·M·S Biomarkers (part of Thermo Fisher Scientific) investigate, develop and manufacture novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With our high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In Future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our Know-How and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

The united systems AG (Germany) was founded in 1999. united systems AG is offering reliable IT infrastructure services based on the international standards of ITIL and ISO 9001.

united systems AG focus on customers with up to 500 seats in the area of „Managed IT Service“ and outsourcing projects. In addition, united systems AG also offers expert consulting around complex Microsoft solutions, Storage solutions, Server and Client Virtualization, Software deployment and Enterprise Archive Solutions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2013 for their kind support:

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

Reaching people, inspiring people, moving people. COMEO is made up of Advertising, PR and Event units. In all three areas, the company builds on a core of permanent specialists with in-depth professional experience, supported by outstanding rookies.

COMEO is the ideal partner for medium-sized companies and institutions from the fields of healthcare, real estate and tourism. Outstanding teamwork and high-grade drive, motivation and commitment are the hallmarks of COMEO’s work. We deliver results that reflect your wishes, comply with your budget and enhance your reputation.

As one of the leading specified developers of pension plans for medium sized companies Connect GmbH accompanies for over 10 years demanding corporate clients with the introduction or optimisation of state promoted operational old-age provisions (BAV) and gets these with it legal security and added value. In particular our long-standing experience, the consultation beginning purely oriented in the customer use and the high social competence in the employee’s consultation are appreciated. In addition we discuss boards of directors, companions and managers in special questions of the property construction and the age security, if necessary in narrow cooperation with specified lawyers and tax consultants.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Feine Sache is a small design and advertising company in Wiesbaden near Frankfurt/Main, Germany. Feine Sache produces corporate design and corporate communication, logos, infographics, illustrations and typography for web, print, and events. Feine Sache works for brands and agencies of any size and also loves to do design for non-for-profit themes. Founded in 2003 by Michel Schmidt, Feine Sache is well-known for its typographic and illustrative skills and enjoys producing design at an international quality level.

So what is good design? Good design is more than creating the surface, and even more than structuring information in a professional way. Good design translates “the whole picture” into a unique graphic language, and in doing so, creates a vision for both, the viewer’s heart and mind.

JOKE Event Inc. is an owner-managed, full-service agency in the field of live communication. Its head office is in Bremen with additional offices in Hamburg, Düsseldorf, Berlin, Frankfurt , Stuttgart and Munich, providing services in close proximity to the clients. The team of JOKE Event Inc. distinguishes itself through imaginative concepts, convincing productions, Hanseatic quality standards, precise, hand-in-hand co-operation with all trades plus a good measure of Nordic understatement. The agency, under the direction of Christian Seidenstücker and Peter Melms, with more than 85 employees ranks among the top ten live-communication agencies nationwide according to the FME Rankings. Since 1992 JOKE Event has provided all event-related services from one source – consulting, creative concepts and realization – for companies, brands and institutions such as the AB Inbev, BMW, Bundesverband WindEnergie e.V. (BEW), Deutscher Stifterverband, Dräger Medical, EFCNI, GP Joule, Hyundai, Kia Motors, Mazda, Kellogg’s, Nissan, Vattenfall or Werder Bremen. JOKE Event founded the “Wolkenschieber”, a charity project in favor of different local charities in and around Bremen.

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

PerkinElmer is a specialist in the identification of disorders during pregnancy and in the first days of a baby’s life. Our focus is on just those diseases where early detection can allow effective treatment. Over the past 25 years PerkinElmer screening tests have been used to check many millions of pregnancies or newborn babies, and it is estimated that currently some 50 babies per day, somewhere in the world are able to move forward to a healthy childhood because their disorder was detected in time by a PerkinElmer test.

During pregnancy, we have pioneered new screening methods for pre-eclampsia which will identify high risk pregnancies already during the first trimester. There is growing evidence that early treatment of the high risk cases can delay or prevent the development of the disease.

The united systems AG (Germany) was founded in 1999. united systems AG is offering reliable IT infrastructure services based on the international standards of ITIL and ISO 9001.

united systems AG focus on customers with up to 500 seats in the area of „Managed IT Service“ and outsourcing projects. In addition, united systems AG also offers expert consulting around complex Microsoft solutions, Storage solutions, Server and Client Virtualization, Software deployment and Enterprise Archive Solutions.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2012 for their kind support:

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

As one of the leading specified developers of pension plans for medium sized companies Connect GmbH accompanies for over 10 years demanding corporate clients with the introduction or optimisation of state promoted operational old-age provisions (BAV) and gets these with it legal security and added value. In particular our long-standing experience, the consultation beginning purely oriented in the customer use and the high social competence in the employee’s consultation are appreciated. In addition we discuss boards of directors, companions and managers in special questions of the property construction and the age security, if necessary in narrow cooperation with specified lawyers and tax consultants.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

DXMCC is your shortcut to professional creative business affairs. Ideas, concepts, design, production and realisation from corporate design projects up to major media solutions.

GETEMED Medizin- und Informationstechnik AG

GETEMED, located in Teltow, Brandenburg, has been developing, manufacturing and selling medical devices in the fields of cardiological diagnostics and vital signs monitoring for over 25 years. In the early years, GETEMED focused mainly on the home monitoring of newborns. Since then, GETEMED has progressed to being a recognised specialist in the ambulatory monitoring of risk patients from all age groups. Furthermore, merging the know-how from both specialised fields has enabled GETEMED to offer customised solutions and innovative treatments for telemedical applications.

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2011 for their kind support:

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

Founded in Parma in 1935, the Chiesi Group focuses on developing drugs for the treatment of respiratory and neonatology ailments and rare diseases. Our drugs are produced at the factories in Parma, Blois (France) and Santana de Parnaiba (Brazil) and sold in 60 countries. Chiesi Group is affiliated with 24 associated companies and employs a staff of 3,700 individuals, 330 of whom are researchers based in Parma and the laboratories in Paris, Rockville (USA) and Chippenham (UK). Chiesi Group earned sales revenue in 2010 of € 1,015 billion reinvesting nearly 15% to Research and Development.

As one of the leading specified developers of pension plans for medium sized companies Connect GmbH accompanies for over 10 years demanding corporate clients with the introduction or optimisation of state promoted operational old-age provisions (BAV) and gets these with it legal security and added value. In particular our long-standing experience, the consultation beginning purely oriented in the customer use and the high social competence in the employee’s consultation are appreciated. In addition we discuss boards of directors, companions and managers in special questions of the property construction and the age security, if necessary in narrow cooperation with specified lawyers and tax consultants.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

DXMCC is your shortcut to professional creative business affairs. Ideas, concepts, design, production and realisation from corporate design projects up to major media solutions.

GETEMED Medizin- und Informationstechnik AG

GETEMED, located in Teltow, Brandenburg, has been developing, manufacturing and selling medical devices in the fields of cardiological diagnostics and vital signs monitoring for over 25 years. In the early years, GETEMED focused mainly on the home monitoring of newborns. Since then, GETEMED has progressed to being a recognised specialist in the ambulatory monitoring of risk patients from all age groups. Furthermore, merging the know-how from both specialised fields has enabled GETEMED to offer customised solutions and innovative treatments for telemedical applications.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2010 for their kind support:

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Bübchen is an experienced and leading brand for babycare products in Germany. Bübchen products give optimal protection and best support for the developing skin. The complete range is produced in Germany, based on natural and effective ingredients. Bübchen only uses such combinations of substances, that guarantee excellent skin-compatibility. All products have as few ingredients as possible to minimize the risk of allergies. They are free of preservatives, perfume, colorants, essential oils.

As one of the leading specified developers of pension plans for medium sized companies Connect GmbH accompanies for over 10 years demanding corporate clients with the introduction or optimisation of state promoted operational old-age provisions (BAV) and gets these with it legal security and added value. In particular our long-standing experience, the consultation beginning purely oriented in the customer use and the high social competence in the employee’s consultation are appreciated. In addition we discuss boards of directors, companions and managers in special questions of the property construction and the age security, if necessary in narrow cooperation with specified lawyers and tax consultants.

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

DXMCC is your shortcut to professional creative business affairs. Ideas, concepts, design, production and realisation from corporate design projects up to major media solutions.

„Paul & Paula“ is Riboth’s new company-owned brand. This soft and absorbent diaper is manufactured from biodegradable and renewable materials, thus providing a unique and smooth baby care. As parents of two preterm children, the owners of Riboth-Group are totally aware of the fact that these babies need special care and attention. “Paul & Paula” is highly motivated to support the activities of EFCNI. We are proud to be EFCNI’s “preemie-partner” right from the beginning.

Riboth.Group is a manufacturer of hygiene products with production sites for diapers and incontinence products located in Germany, Poland and France. The highly flexible production lines and innovative processes guarantee Riboth’s high quality standards not only for the private label sector but also for the company-owned brands in the European and additional markets.

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2009 for their kind support:

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank our Project Partners 2009 for their kind support:

How to become a Project Partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Project Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.